Literature DB >> 19186969

Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.

Lars K Sørensen1, Anne Havemose-Poulsen, Klaus Bendtzen, Palle Holmstrup.   

Abstract

BACKGROUND: Cytokines and cytokine inhibitors have been associated with many immunoinflammatory diseases. In the present study, we examined whether peripheral blood mononuclear cell (PBMC) gene expression mirrors the corresponding plasma levels of clinically important pro- and anti-inflammatory cytokines and cytokine receptors in patients with periodontitis and patients with arthritis representing two examples of chronic inflammatory diseases, such as periodontitis and arthritis. To identify possible disease-specific characteristics of subjects with periodontitis relative to subjects with chronic inflammation in general, patients with arthritis (juvenile idiopathic arthritis [JIA] and rheumatoid arthritis [RA]) were included.
METHODS: The study population consisted of white adults <35 years of age diagnosed with localized aggressive periodontitis (LAgP; n = 18), generalized aggressive periodontitis (GAgP; n = 27), JIA (n = 10), and RA (n = 23) and healthy controls (n = 25). PBMC transcripts of interleukin (IL) 1 alpha (IL1A), IL 1 beta (IL1B), IL 1 receptor antagonist (IL1RN), IL6, IL10, tumor necrosis factor alpha (TNFA), TNF alpha receptor I (TNFRI), and TNFRII were measured using real-time reverse transcription-polymerase chain reaction and compared to the corresponding plasma protein levels measured by enzyme-linked immunosorbent assay and a multiplex antibody bead assay.
RESULTS: Compared to controls, soluble (s) TNF-RII levels were significantly elevated in patients with GAgP (P = 0.001) or JIA (P = 0.002), and PBMC TNFA transcript levels were lower in patients with JIA (P = 0.001). A negative correlation was found between IL6 expression and IL-6 plasma levels in patients with JIA versus controls, and a positive correlation/association was found between TNFRI expression and sTNF-RI plasma levels in patients with LAgP and RA.
CONCLUSIONS: The study demonstrated only a few changes in the PBMC expression of various cytokine and cytokine inhibitor genes in aggressive periodontitis and chronic arthritis compared to controls. There were a few similarities among disease groups, and no direct and simple correlation between cellular transcripts and proteins was found.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186969     DOI: 10.1902/jop.2009.080347

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer.

Authors:  Juliana Garcia de Oliveira; Ana Flávia Teixeira Rossi; Daniela Manchini Nizato; Aline Cristina Targa Cadamuro; Yvana Cristina Jorge; Marina Curado Valsechi; Larissa Paola Rodrigues Venâncio; Paula Rahal; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo; Ana Elizabete Silva
Journal:  Tumour Biol       Date:  2015-06-19

Review 2.  Host Responses in the Link Between Periodontitis and Rheumatoid Arthritis.

Authors:  Tetsuo Kobayashi; Hiromasa Yoshie
Journal:  Curr Oral Health Rep       Date:  2015

Review 3.  Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?

Authors:  Mena Soory
Journal:  Open Access Rheumatol       Date:  2010-05-28

Review 4.  Recent advances in neutralizing the IL-6 pathway in arthritis.

Authors:  Charles J Malemud
Journal:  Open Access Rheumatol       Date:  2009-10-05

5.  CpG Single-Site Methylation Regulates TLR2 Expression in Proinflammatory PBMCs From Apical Periodontitis Individuals.

Authors:  María José Bordagaray; Alejandra Fernández; Jessica Astorga; Mauricio Garrido; Patricia Hernández; Alejandra Chaparro; María Jesús Lira; Peter Gebicke-Haerter; Marcela Hernández
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.